mGluR5 inhibitors (Purdue)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamemGluR5 inhibitors (Purdue)
Drug Alias Namemetabotropic glutamate receptor 5 inhibitors (Purdue)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 antagonists
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue Pharma Lp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue Pharma Lp
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A